We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$18.3B
AUM Growth
+$1.38B
Cap. Flow
-$639M
Cap. Flow %
-3.49%
Top 10 Hldgs %
37.51%
Holding
256
New
14
Increased
34
Reduced
47
Closed
63

Sector Composition

Rank Sector Weight
1 Healthcare 33.33%
2 Technology 18.46%
3 Financials 12.48%
4 Industrials 7.09%
5 Communication Services 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGTIW icon
176
Rigetti Computing Warrants
RGTIW
$178M
$2.71K ﹤0.01%
22,675
NSTD.WS
177
DELISTED
Northern Star Investment Corp. IV Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTD.WS
$797 ﹤0.01%
16,666
TIOAW
178
DELISTED
Tio Tech A Warrants
TIOAW
$700 ﹤0.01%
166,666
ABBV icon
179
AbbVie
ABBV
$468B
-939,212
Closed -$152M
AEON icon
180
AEON Biopharma
AEON
$9.58M
-2,083
Closed -$1.51M
CLVT icon
181
Clarivate
CLVT
$1.33B
-15,177,433
Closed -$127M
CVS icon
182
CVS Health
CVS
$119B
-694,259
Closed -$64.7M
FHN icon
183
First Horizon
FHN
$11.7B
-455,000
Closed -$11.1M
GBIO
184
DELISTED
Generation Bio
GBIO
-124,938
Closed -$4.91M
GPOR icon
185
Gulfport Energy Corp
GPOR
$3.07B
-116,020
Closed -$8.54M
LUNR icon
186
Intuitive Machines
LUNR
$2.94B
-1,900,000
Closed -$19M
OPAL icon
187
OPAL Fuels
OPAL
$64.4M
-35,725
Closed -$260K
TNGX icon
188
Tango Therapeutics
TNGX
$4.03B
-270,000
Closed -$1.96M
BCSA
189
DELISTED
Blockchain Coinvestors Acquisition Corp. I Class A Ordinary Shares
BCSA
-300,000
Closed -$3.09M
JWSM
190
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
-800,000
Closed -$8.08M
MVLA
191
DELISTED
Movella Holdings Inc. Common Stock
MVLA
-750,000
Closed -$7.56M
VAQC
192
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
-1,700,000
Closed -$17.2M
GOL
193
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
-85,838
Closed -$229K
DISA
194
DELISTED
Disruptive Acquisition Corporation I Class A Ordinary Shares
DISA
-1,400,000
Closed -$14.1M
IPVF
195
DELISTED
InterPrivate III Financial Partners Inc.
IPVF
-400,000
Closed -$4.07M
MPRA
196
DELISTED
Mercato Partners Acquisition Corporation Class A Common Stock
MPRA
-750,000
Closed -$7.69M
NSTC
197
DELISTED
Northern Star Investment Corp. III
NSTC
-100,000
Closed -$1M
FMIV
198
DELISTED
Forum Merger IV Corporation Class A Common stock
FMIV
-1,000,000
Closed -$10.1M
IPVI
199
DELISTED
InterPrivate IV InfraTech Partners Inc. Class A Common Stock
IPVI
-600,000
Closed -$6.15M
SGFY
200
DELISTED
Signify Health, Inc.
SGFY
-3,950,000
Closed -$113M

Similar funds

Thomas Steyer's Q1 2023 Portfolio in Review

As of Q1 2023, Thomas Steyer held 256 positions worth $18.3B, up 8.2% from $16.9B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Thomas Steyer withdrew a net $639M in Q1 2023, closing 63 positions and reducing 47 holdings. Its most notable exit was AbbVie, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in UnitedHealth worth $409M.

  • Thomas Steyer's largest Q1 2023 buy was UnitedHealth: 866,000 shares worth $409M.
  • Thomas Steyer added most to Alphabet (Google) Class C in Q1 2023, an estimated $235M increase.
  • Thomas Steyer's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $87M.
  • Thomas Steyer fully exited AbbVie in Q1 2023, selling an estimated $152M.
  • Thomas Steyer's ten largest holdings make up 38% of its $18.3B portfolio in Q1 2023.
  • Thomas Steyer opened 14 new positions and closed 63 in Q1 2023.
  • Thomas Steyer's portfolio value rose 8.2% quarter-over-quarter to $18.3B.

Based on Farallon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.